Domov › Fokalna segmentna glomeruloskleroza › Kalifornija
Klinične študije za Fokalna segmentna glomeruloskleroza v Kalifornija
8 študij za Fokalna segmentna glomeruloskleroza išče udeležence na lokacijah v Kalifornija.
Mesta v Kalifornija
Uradno besedilo študije (angleško)
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
- Investigator Site #2, Chula Vista
- Investigator Site #28, Garden Grove
- Investigator Site #14, Los Angeles
- in še 1
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT07268638A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
- West Coast Kidney Institute, Fremont
- Kidney Disease Medical Group, Glendale
- Valiance Clinical Research, Huntington Park
- in še 8
Vključevanje udeležencevFaza 3
Starost 12 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07220083A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- University of California Irvine Medical Center- Site Number : 8400015, Orange
- University of California San Francisco - Parnassus Heights- Site Number : 8400012, San Francisco
Vključevanje udeležencevFaza 2
Starost 16–75 · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT06500702Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System
- Loma Linda University Children's Hospital, Loma Linda
- Loma Linda University Hospital, Loma Linda
Vključevanje udeležencev
Do 75 let · Vsi spoli · Posodobljeno 28. avg. 2026 · NCT04065438Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- Loma Linda University Children's Hospital, Loma Linda
- Cedars Sinai Medical Center, Los Angeles
Vključevanje udeležencev
Do 21 let · Vsi spoli · Posodobljeno 28. avg. 2026 · NCT02235857Nephrotic Syndrome Study Network
- University of Southern California-Children's Hospital, Los Angeles
- Stanford University School of Medicine, Palo Alto
- University of California San Francisco Benioff Children's Hospitals, San Francisco
- in še 1
Vključevanje udeležencevOpazovalna študija
Do 80 let · Vsi spoli · Posodobljeno 10. jun. 2026 · NCT01209000Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- Cedars-Sinai Medical Center, Los Angeles
Vključevanje udeležencevFaza 2
Starost 1–17 · Vsi spoli · Posodobljeno 12. maj 2026 · NCT05003986A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
- Cedars-Sinai Medical Center, Los Angeles
- University of California, Los Angeles, Los Angeles
- Kaiser Permanente, Oakland
- in še 2
Vključevanje udeležencevFaza 3
Starost 12–80 · Vsi spoli · Posodobljeno 3. feb. 2026 · NCT05183646Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.